FDA Seeks Risk-Based Inspection Program

Pharmaceutical Technology, Pharmaceutical Technology-11-02-2003, Volume 27, Issue 11

FDA's new policies intend to make GMP inspections more efficient and apply to stricter rules to high-risk products and processes.